Current therapy of persistent pulmonary hypertension of the newborn (PPHN) consists of optimal ventilation, hemodynamic support and selective vasodilatation with inhaled nitric oxide (iNO). We present herein a case of PPHN non-responsive to iNO but treated successfully with a combination of iNO and intravenous milrinone, a phosphodiesterase III inhibitor. This case suggests that the drug may be a useful adjunctive treatment in the management of PPHN.
|Number of pages||3|
|Journal||Turkish Journal of Pediatrics|
|Publication status||Published - Jan 2010|
- Phosphodiesterase III inhibitor
- Pulmonary hypertension
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health